These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 19856430)

  • 1. Another quest for a solution... and when a dedicated device?
    Bonan R
    Catheter Cardiovasc Interv; 2009 Nov; 74(5):691-2. PubMed ID: 19856430
    [No Abstract]   [Full Text] [Related]  

  • 2. Better results with the new generation bare metal stents.
    Vik-Mo H
    Scand Cardiovasc J; 2009 Apr; 43(2):84-6. PubMed ID: 19117238
    [No Abstract]   [Full Text] [Related]  

  • 3. Angiographic restenosis and clinical recurrence after sirolimus- and paclitaxel-eluting stent implantation.
    Vlaar PJ; Zijlstra F
    JACC Cardiovasc Interv; 2009 Aug; 2(8):776-8. PubMed ID: 19695547
    [No Abstract]   [Full Text] [Related]  

  • 4. A critical appraisal of the Janus carbostent.
    Kornowski R
    Catheter Cardiovasc Interv; 2009 Feb; 73(2):249-50. PubMed ID: 19156897
    [No Abstract]   [Full Text] [Related]  

  • 5. Carina modification T stenting, a new bifurcation stenting technique: clinical and angiographic data from the first 156 consecutive patients.
    Al Rashdan I; Amin H
    Catheter Cardiovasc Interv; 2009 Nov; 74(5):683-90. PubMed ID: 19496132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. eComment: How to reconstruct endarterectomized left anterior descending coronary artery.
    Nezic D; Knezevic A; Cirkovic M; Micovic S
    Interact Cardiovasc Thorac Surg; 2009 Oct; 9(4):738. PubMed ID: 19773244
    [No Abstract]   [Full Text] [Related]  

  • 7. Sirolimus- versus paclitaxel-eluting stents for the treatment of cardiac allograft vasculopathy.
    Lee MS; Tarantini G; Xhaxho J; Yang T; Ehdaie A; Bhatia R; Favaretto E; Tobis J
    JACC Cardiovasc Interv; 2010 Apr; 3(4):378-82. PubMed ID: 20398863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical aspects of excimer laser angioplasty for undilatable lesions.
    Bittl JA
    Catheter Cardiovasc Interv; 2008 May; 71(6):808-9. PubMed ID: 18412077
    [No Abstract]   [Full Text] [Related]  

  • 9. Is CT the better angiogram? Coronary interventions and CT imaging.
    Achenbach S; Ludwig J
    JACC Cardiovasc Imaging; 2010 Jan; 3(1):29-31. PubMed ID: 20129527
    [No Abstract]   [Full Text] [Related]  

  • 10. Unprotected left main bifurcation restenosis treated with a 2-stent technique.
    Wainstein MV; Wainstein RV; Ribeiro JP
    Catheter Cardiovasc Interv; 2013 Sep; 82(3):E200-5. PubMed ID: 22972629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bare metal stent thrombosis 13 years after implantation.
    Sarkees ML; Bavry AA; Galla JM; Bhatt DL
    Cardiovasc Revasc Med; 2009; 10(1):58-9. PubMed ID: 19159857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The "mini-crush" technique for managing bifurcation lesions.
    Kornowski R
    Catheter Cardiovasc Interv; 2009 Jul; 74(1):85-7. PubMed ID: 19530202
    [No Abstract]   [Full Text] [Related]  

  • 13. Stent strut fracture: seeing is believing.
    Carter AJ
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):619-20. PubMed ID: 18360854
    [No Abstract]   [Full Text] [Related]  

  • 14. Restenosis in a Collapsed Magnesium Bioresorbable Scaffold.
    Barkholt TØ; Neghabat O; Terkelsen CJ; Christiansen EH; Holm NR
    Circ Cardiovasc Interv; 2017 Oct; 10(10):. PubMed ID: 29042399
    [No Abstract]   [Full Text] [Related]  

  • 15. Restenosis following thin-strut bare-metal stents versus thick-strut drug-eluting stents.
    Moliterno DJ
    Catheter Cardiovasc Interv; 2007 May; 69(6):799-800. PubMed ID: 17377984
    [No Abstract]   [Full Text] [Related]  

  • 16. Five-year long-term clinical follow-up of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: the SPIRIT FIRST trial.
    Wiemer M; Serruys PW; Miquel-Hebert K; Neumann FJ; Piek JJ; Grube E; Haase J; Thuesen L; Hamm C
    Catheter Cardiovasc Interv; 2010 Jun; 75(7):997-1003. PubMed ID: 20517959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A generation 2.5 drug-eluting stent?
    Ellis SG
    JACC Cardiovasc Interv; 2009 Oct; 2(10):986-8. PubMed ID: 19850259
    [No Abstract]   [Full Text] [Related]  

  • 18. In-hospital and 1-year outcomes among unselected percutaneous coronary intervention patients treated with either sirolimus- or paclitaxel-eluting stents: results from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry.
    Novack V; Cutlip D; Kleiman N; Pencina M; Mauri L; Yen CH; Berger P; Goldberg S; Kellett M; Waksman R; Hong M; Raizner AE; Cohen DJ
    JACC Cardiovasc Interv; 2009 Aug; 2(8):767-75. PubMed ID: 19695546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DES in CTO: cosmetic or clinical benefit.
    Goyal BK
    Catheter Cardiovasc Interv; 2009 May; 73(6):780. PubMed ID: 19370758
    [No Abstract]   [Full Text] [Related]  

  • 20. A randomized controlled trial of angiography versus intravascular ultrasound-directed bare-metal coronary stent placement (the AVID Trial).
    Russo RJ; Silva PD; Teirstein PS; Attubato MJ; Davidson CJ; DeFranco AC; Fitzgerald PJ; Goldberg SL; Hermiller JB; Leon MB; Ling FS; Lucisano JE; Schatz RA; Wong SC; Weissman NJ; Zientek DM;
    Circ Cardiovasc Interv; 2009 Apr; 2(2):113-23. PubMed ID: 20031704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.